Yogesh Agrawal

The company had posted a net profit after tax, minority interest and share of profit of associates of Rs 103.44 crore for the same period of the previous fiscal, Ajanta Pharma said in a filing to BSE.

Ajanta Pharma's Guwahati facility to be ready by Mar 2017

Drug maker Ajanta Pharma said its new formulations facility at Guwahati will be commercialised before March 2017 and Dahej manufacturing facility, mainly dedicated for developed markets, will be operational in next financial year.

Planning capex of Rs 300 cr at Guwahati plant: Ajanta Pharma

On the sidelines of the Antique Investor Conference, Yogesh Agrawal, Md of Ajanta Pharma told CNBC-TV18 that the company has filed for 5 Abbreviated New Drug Application‘s (ANDA) of which 2 tentative approvals may be launched in the near future.

Time Inc. Names Winners of Inaugural TIME India Awards at Make In India Week in Mumbai

Today, Time Inc. announced the winners of the inaugural TIME India Awards, honoring leaders for manufacturing excellence in India, at the Make in ...

Time Inc. Names Winners of Inaugural TIME India Awards at Make In India Week in Mumbai

Today, Time Inc. announced the winners of the inaugural TIME India Awards, honoring leaders for manufacturing excellence in India, at the Make in ...